Dr Ana-Maria Boie, Boehringer Ingelheim Korea’s general manager (second from right) and Ms Eleanor Tan, Boehringer Ingelheim’s patient engagement lead for the ASKAN region (far right) at a ...

Boehringer Ingelheim is strengthening its commitment to positively impact people, animals, communities and the planet through key sustainability initiatives in the Philippines and across ASEAN ...

Besides empowering employees to do good, Boehringer Ingelheim also engages them through a cross-functional team named ASKAN Cares, which creates holistic programmes themed around physical, social ...

Boehringer Ingelheim is one of 15 global Top Employers worldwide Achieved Global Recognition and Top Employer Certification in 29 countries From Top Employers Institute® Outstanding employer ...

Cognizant (Nasdaq: CTSH) and Boehringer Ingelheim announced today the go-live of an end-to-end technology platform powered by the Veeva Development Cloud, designed to accelerate the global ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 revenues, buoyed by diabetes drug Jardiance and lung drug Ofev.

Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, announced a new partnership in China on Monday, and remains upbeat about the market amid strains between Beijing and ...

BOEHRINGER INGELHEIM has been recognized for the third year in succession as "Global Top Employer" by the Top Employers Institute, one of the world's 15 best employers. Regionally, it has been ...